Key facts
- Activist investor Ananym Capital Management has acquired a stake in Bio-Techne.
- Ananym Capital is urging Bio-Techne's board to conduct a strategic review.
- The review may include a potential sale of the company.
Activist investor Ananym Capital Management has acquired a stake in Bio-Techne. The firm is urging the company's board to initiate a strategic review, which may involve a sale of the company.